Rockwell Medical to Present at Noblecon18 Investor Conference

Rhea-AI Summary

Rockwell Medical, a biopharmaceutical company focused on iron deficiency and anemia treatment, will present at the Noblecon18 Annual Investor Conference on April 21, 2022, at 10:00 AM ET in Hollywood, Florida. A video webcast will be available the next day on the Rockwell Medical website and will remain archived for 90 days. Rockwell Medical is known for its Ferric Pyrophosphate Citrate platform and offers FDA-approved solutions for patients on hemodialysis, alongside plans to expand into home infusion settings.

WIXOM, Mich., April 20, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients, today announced that the company is scheduled to present at the Noblecon18, Noble Capital Market's 18^th Annual Investor Conference in Hollywood, Florida, on Thursday, April 21^st at 10:00 AM ET.

A video webcast of the presentation will be available the following day on the Rockwell Medical website. The webcast will be archived on the company's website, the NobleCon website and on Channelchek.com for 90 days following the event.

About Rockwell Medical

Rockwell Medical is a commercial-stage biopharmaceutical company developing and commercializing its next-generation parenteral iron technology platform, Ferric Pyrophosphate Citrate (FPC), which has the potential to lead transformative treatments for iron deficiency in multiple disease states, reduce healthcare costs and improve patients' lives. The Company has two FDA-approved therapies indicated for patients undergoing hemodialysis, which are the first two products developed from the FPC platform. Rockwell Medical is also seeking to advance its FPC platform by developing FPC for the treatment of iron deficiency anemia in patients outside of dialysis, who are receiving intravenous medications in the home infusion setting. In addition, Rockwell Medical is one of two major suppliers of life-saving hemodialysis concentrate products to kidney dialysis clinics in the United States. For more information, visit www.RockwellMed.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rockwell-medical-to-present-at-noblecon18-investor-conference-301528774.html

SOURCE Rockwell Medical Technologies, Inc.

FAQ

What is Rockwell Medical scheduled to present at Noblecon18?

Rockwell Medical will present on April 21, 2022, at the Noblecon18 Annual Investor Conference.

When is the Noblecon18 Investor Conference taking place?

The Noblecon18 Investor Conference is scheduled for April 21, 2022.

At what time will Rockwell Medical's presentation occur?

Rockwell Medical's presentation will be at 10:00 AM ET.

Where can I watch Rockwell Medical's presentation?

The presentation will be available via a video webcast on the Rockwell Medical website the day after the event.

How long will the webcast of Rockwell Medical's presentation be available?

The webcast will be archived for 90 days following the event.

What is the focus of Rockwell Medical's biopharmaceutical developments?

Rockwell Medical focuses on transforming treatments for iron deficiency and managing anemia.